| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |